The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study

Abstract Background Chemotherapies are still widely used in advanced breast cancer, specifically in patients with HER2-negative disease. This non-interventional real-world study assessed the utilization of nab-paclitaxel in a broad patient population with advanced breast cancer. Methods SERAPHINA (N...

全面介紹

書目詳細資料

發表在:	Journal of Cancer Research and Clinical Oncology
Main Authors:	Andreas Schneeweiss, Peter A. Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Hans Tesch, Tanja N. Fehm, Tjoung-Won Park-Simon, Lothar Häberle, Sabrina Uhrig, Oliver Tome, Thomas Spall, Anna-Katharin Theuser, Matthias Ruebner, Erik Belleville, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf
格式:	Article
語言:	英语
出版:	Springer 2025-06-01
主題:	Advanced breast cancer Nab-paclitaxel Chemotherapy Real-world Non-interventional study
在線閱讀:	https://doi.org/10.1007/s00432-025-06246-2